Journal of the World Aquaculture Society · مجلد 56 (2)
Abstract Maintaining a healthy intestine is essential for growth and host defense mechanisms of farmed fish, particularly those densely stocked. In this context, maintaining a healthy intestinal microbiota for proper digestion, absorption, and integrity of the mucosa is of utmost importance. Nano‐form (SeNPs)‐enriched‐Pediastrum boryanum (Turpin) exhibits antimicrobial, antioxidant, and antitumor properties. Therefore, SeNPs are valuable nutritional supplements for farmed aquatic animals. Algogenic Se nanoparticles (SeNPs, 79.26 nm) were synthesized from the green microalga Pediastrum boryanum. A Nile tilapia (Oreochromis niloticus) basal diet was blended with 0.75 or 1.5 mg/kg dry feed of the SeNPs for and fed for 8 weeks. Comprehensive arrays of intestinal biomarker‐related parameters were investigated. Supplementation with SeNPs, particularly at a 1.5 mg/kg diet, improved growth performance, amylase and lipase activity, serotonin metabolite level, and intestinal morphometry. In addition, SeNPs supplementation suppressed serotonin levels. SeNPs at a 1.5 mg/kg diet were observed to be the optimal dose, as they showed better results concerning the increase in beneficial microbes and decrease in pathogenic microbes, demonstrating the potential role of SeNPs in growth improvement and enhanced intestinal functions. The sum of our data underscores the benefits of supplementing Nile tilapia feed with SeNPs to promote the growth and profitability of aquaculture.
Journal of Advanced Trends in Medical Research · مجلد 2 (3) · 596-601
Background: Non-alcoholic fatty liver disease (NAFLD) is one of the causes of chronic liver diseases. Inconsistency in the microbiome population of individual guts and host–microbial interactions leads to low response in dietary and pharmacological-based treatments. This study aimed to develop and evaluate a metagenomic-guided, culturally adapted dietary and probiotic intervention to reduce hepatic fat and improve metabolic outcomes in obese Saudi adults with NAFLD. Materials and Methods: We combined gut metagenomic analysis, machine learning-based diet modelling and tailored probiotic supplementation to create an intervention platform. Probiotic specificity depends on functional deficits in bacteria participating in specific metabolic pathways, particularly bile acid metabolism. This technique supplements medication with microbiome-based drug processing. Results: At week 24, magnetic resonance imaging–proton density fat fraction (MRI-PDFF) decreased by −3.4 ± 2.2% (control), −8.9 ± 3.1% (diet) and −12.3 ± 3.8% (diet + probiotics); liver fat reduction was significant (analysis of variance (ANOVA) P = 0.0004). In the combined intervention, Faecalibacterium prausnitzii increased 2.3-fold (P = 0.003), faecal butyrate rose from 28.7 ± 4.1 to 45.2 ± 5.6 μmol/g (P = 0.002), faecal deoxycholic acid (fDCA) fell 34% (P = 0.010) with a rise in ursodeoxycholic acid (UDCA) (P = 0.015) and high-sensitivity C-reactive protein declined 42% (6.4 ± 1.7 to 3.7 ± 1.3 mg/L) versus 18% in controls (between-group P = 0.0008). Conclusion: Our precision-guided approach is a novel, scalable solution to managing NAFLD, leveraging the alignment of interactions between hosts, the microbiome and diet within a cultural context. The framework has the potential to optimise therapeutic response in high-risk Saudi communities, and the individual modulation of microbiomes on metabolic diseases is highlighted.
Journal of Advanced Trends in Medical Research · مجلد 2 (1) · 69-75
Abstract Background: Preoperative immunonutrition is a promising approach to enhance surgical outcomes in high-risk populations, such as pediatric patients with chronic kidney disease (CKD). However, conventional protocols often fail to account for individual biological variability, limiting their effectiveness. Objectives: To develop a precision-based immunonutrition framework that integrates multi-omic data to predict individual responses and tailor nutritional interventions in pediatric CKD patients undergoing surgery. Methods: Our approach combines gut microbiome composition, host gene expression, and metabolic profiles using canonical correlation analysis (CCA) to extract latent multi-omic interactions. These features are then used to train a random forest classifier that predicts immunonutrition responsiveness with probabilistic scoring. The system dynamically adjusts interventions, including arginine and omega-3 fatty acid supplementation, based on predicted response levels. The framework leverages high-throughput sequencing, metabolomics, and scalable computing for real-time clinical integration. Results: The proposed system successfully predicted patient-specific responses to immunonutrition and supported personalized adjustments. It integrates smoothly with standard dietitian workflows and enhances clinical decision-making through data-driven insights. In pediatric CKD contexts, this approach demonstrated a marked potential for reducing post-operative complications. Conclusion: By shifting from a generalized to a precision-based paradigm, this framework lays the groundwork for individualized immunonutrition strategies in vulnerable pediatric populations. The model offers clinical scalability and may significantly improve surgical outcomes, particularly in personalized care settings like Saudi Arabia.